| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| QUIPT HOME MEDICAL Aktie jetzt für 0€ handeln | |||||
| 06.01. | Quipt Home Medical Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 19.12.25 | The Quipt deal is good for shareholders, Leede says | 1 | Cantech Letter | ||
| 16.12.25 | Quipt Home Medical stock to be acquired by Kingswood and Forager for $3.65 per share | 2 | Investing.com | ||
| 15.12.25 | Quipt Home Medical Corp: Quipt signs deal for acquisition by Kingswood, Forager | 1 | Stockwatch | ||
| 15.12.25 | Stocks in Play: Quipt Home Medical Corp. | 3 | Baystreet.ca | ||
| 15.12.25 | Quipt Home Medical stock downgraded to Sell by Stifel on acquisition news | 2 | Investing.com | ||
| 15.12.25 | Quipt Home Medical GAAP EPS of -$0.08, revenue of $68.3M | 2 | Seeking Alpha | ||
| 15.12.25 | Quipt Home Medical Corp.: Quipt Home Medical Enters Into Definitive Agreement for Its Acquisition by Affiliates of Kingswood Capital Management and Forager Capital Management | 223 | GlobeNewswire (Europe) | Quipt shareholders to receive US$3.65 per share in cashTransaction provides immediate liquidity and certainty of value to shareholdersThe per share purchase price represents a 162% premium to Quipt's... ► Artikel lesen | |
| 15.12.25 | Quipt Home Medical Corp. - 10-K, Annual Report | - | SEC Filings | ||
| 15.12.25 | Quipt Home Medical Corp. - 8-K, Current Report | - | SEC Filings | ||
| 05.12.25 | Quipt Home Medical holder urgers board to pursue a sale | 2 | Seeking Alpha | ||
| 22.10.25 | Lakeview Investment Group urges Quipt to engage with bidder | 1 | Investing.com | ||
| 11.09.25 | Quipt Home Medical Corp: Quipt holder/suitor Forager highlights premium in offer | 3 | Stockwatch | ||
| 04.09.25 | Quipt Home Medical Corp: Quipt holder/suitor Forager rips "self-serving" board | 5 | Stockwatch | ||
| 03.09.25 | Quipt Home Medical Corp: Quipt closes acquisition of 60% of Hart | 2 | Stockwatch | ||
| 03.09.25 | Quipt Home Medical completes strategic acquisition of Hart Medical for $17.4M | 2 | Seeking Alpha | ||
| 03.09.25 | Quipt Home Medical Corp.: Quipt Home Medical Completes Strategic Acquisition of Hart Medical Adding $60 Million in Revenue | 329 | GlobeNewswire (Europe) | CINCINNATI, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory... ► Artikel lesen | |
| 27.08.25 | Quipt Home Medical Corp: Quipt receives another unsolicited offer from Forager | 1 | Stockwatch | ||
| 27.08.25 | Stocks in Play: Quipt Home Medical Corp. | 3 | Baystreet.ca | ||
| 27.08.25 | Quipt Home Medical Corp. - 8-K, Current Report | 2 | SEC Filings |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 37,680 | -4,22 % | EQS-Adhoc: Fresenius Medical Care AG: Fresenius Medical Care AG setzt Aktienrückkaufprogramm beschleunigt fort | EQS-Ad-hoc: Fresenius Medical Care AG / Schlagwort(e): Aktienrückkauf
Fresenius Medical Care AG: Fresenius Medical Care AG setzt Aktienrückkaufprogramm beschleunigt fort
09.01.2026... ► Artikel lesen | |
| FAMICORD | 5,950 | -0,83 % | EQS-News: FamiCord AG beschleunigt profitables Wachstum im dritten Quartal 2025 und stärkt Qualität und Visibilität der Umsatzentwicklung | EQS-News: FamiCord AG
/ Schlagwort(e): 9-Monatszahlen
FamiCord AG beschleunigt profitables Wachstum im dritten Quartal 2025 und stärkt Qualität und Visibilität der Umsatzentwicklung... ► Artikel lesen | |
| M1 KLINIKEN | 17,720 | -1,99 % | M1 Kliniken: Zimmnau in den Vorstand berufen | M1 Kliniken erweitert den Vorstand: Einer Meldung des Berliner Unternehmens vom Donnerstag zufolge hat man "Katharina Zimmnau mit Wirkung zum 10.12.2025 in den Vorstand der M1 Kliniken AG berufen".... ► Artikel lesen | |
| BAXTER | 16,760 | -0,69 % | Baxter introduces new hospital stretcher | ||
| MEDICLIN | 3,800 | +1,06 % | EQS-News: MEDICLIN AG: Dr. Joachim Ramming verlässt den Vorstand der MEDICLIN AG zum Ende des Geschäftsjahres 2025 | EQS-News: MEDICLIN AG
/ Schlagwort(e): Personalie
Dr. Joachim Ramming verlässt den Vorstand der MEDICLIN AG zum Ende des Geschäftsjahres 2025
16.12.2025 / 15:00 CET/CEST
Für... ► Artikel lesen | |
| DAVITA | 91,56 | +2,07 % | Community Health Experience: DaVita and Collaborators Are Bringing Health Access Closer to Home | NORTHAMPTON, MA / ACCESS Newswire / January 13, 2026 / For many in under-resourced communities, barriers such as unreliable transportation, language, insufficient insurance coverage and limited access... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc. - 8-K, Current Report | ||
| CO-DIAGNOSTICS | 2,360 | 0,00 % | Co-Diagnostics droht Delisting von der NASDAQ - Handel soll im OTC-Markt fortgesetzt werden | ||
| CYTOSORBENTS | 0,585 | -6,40 % | Cytosorbents Corp: CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update | Fourth quarter and Full-Year 2025 revenue are expected to be approximately $9.2 million and $37.0 million, respectively, with expected Q4 gross margins in the range... ► Artikel lesen | |
| LIMES SCHLOSSKLINIKEN | 378,00 | +0,53 % | EQS-DD: Limes Schlosskliniken AG: GMF Capital GmbH, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
18.12.2025 / 11:21... ► Artikel lesen | |
| SENSEONICS | 6,050 | 0,00 % | Senseonics reports 71% revenue growth in Q4, guides higher for 2026 | ||
| VIROMED MEDICAL | 4,200 | 0,00 % | EQS-News: Viromed Medical AG: Viromed AG: Strategisches Update zur operativen Ausrichtung und Wertschöpfungsfokus | EQS-News: Viromed Medical AG
/ Schlagwort(e): Sonstiges
Viromed AG: Strategisches Update zur operativen Ausrichtung und Wertschöpfungsfokus
07.01.2026 / 14:15 CET/CEST
Für... ► Artikel lesen | |
| UNIVERSAL HEALTH SERVICES | 173,00 | -0,57 % | Universal Health Services stock price target lowered to $245 at TD Cowen | ||
| BIOCEPT | 7,200 | 0,00 % | GlaxoSmithKline Bioc: Gewinn im zweiten Quartal bei 5,9 Mio. EGP | ||
| DELCATH SYSTEMS | 8,900 | -0,56 % | DELCATH SYSTEMS, INC. - 8-K, Current Report |